Coenzyme Q for children with ADHD
Treatments studied
Part of Mental health clinical trials.
This trial tests whether taking coenzyme Q can improve symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. It may help if your child has ADHD, but it excludes certain other conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with ADHD
- Your child does not have autism
- Your child does not have an anxiety disorder
- Your child does not have obsessive-compulsive disorder (OCD)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether omega-3 fatty acids can improve attention and hyperactivity in people with ADHD. It compares omega-3 treatment against a placebo to see if it helps reduce symptoms.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
This study tests whether a medication called atomoxetine, which is already used for ADHD, can also help reduce bedwetting at night in children with ADHD. It aims to provide a new treatment option for children who have not improved with other approaches.
This study checks whether atomoxetine, a medicine for ADHD, affects the heart health of children. It aims to make sure the treatment is safe for kids who are just starting it.
This study tests whether a probiotic supplement can help children with mild ADHD by improving communication between the gut and the brain. It may offer a natural way to support focus and behavior.
This trial tests starting a new medication (Methylphenidate or Guanfacine) in young children with moderate or severe ADHD to see how well it works and if it’s safe.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.